 |
The Journal of Neuroscience, July 7, 2004, 24(27):6144-6151; doi:10.1523/JNEUROSCI.1090-04.2004
Previous Article | Next Article 
Neurobiology of Disease
Passive Amyloid Immunotherapy Clears Amyloid and Transiently Activates Microglia in a Transgenic Mouse Model of Amyloid Deposition
Donna M. Wilcock,1,2
Amyn Rojiani,1,3,4
Arnon Rosenthal,5
Gil Levkowitz,5
Sangeetha Subbarao,5
Jennifer Alamed,1,2
David Wilson,1,2
Nedda Wilson,1,2
Melissa J. Freeman,1,2
Marcia N. Gordon,1,2 and
Dave Morgan1,2
1Alzheimer's Research Laboratory and Departments of 2Pharmacology, 3Interdisciplinary Oncology, and 4Pathology, University of South Florida, Tampa, Florida 33612, and 5Rinat Neuroscience Corporation, Palo Alto, California 94304
The role of microglia in the removal of amyloid deposits after systemically administered anti-A antibodies remains unclear. In the current study, we injected Tg2576 APP transgenic mice weekly with an anti-A antibody for 1, 2, or 3 months such that all mice were 22 months at the end of the study. In mice immunized for 3 months, we found an improvement in alternation performance in the Y maze. Histologically, we were able to detect mouse IgG bound to congophilic amyloid deposits in those mice treated with the anti-A antibody but not in those treated with a control antibody. We found that Fc receptor expression on microglia was increased after 1 month of treatment, whereas CD45 was increased after 2 months of treatment. Associated with these microglial changes was a reduction in both diffuse and compact amyloid deposits after 2 months of treatment. Interestingly, the microglia markers were reduced to control levels after 3 months of treatment, whereas amyloid levels remained reduced. Serum A levels and anti-A antibody levels were elevated to similar levels at all three survival times in mice given anti-A injections rather than control antibody injections. These data show that the antibody is able to enter the brain and bind to the amyloid deposits, likely opsonizing the A and resulting in Fc receptor-mediated phagocytosis. Together with our earlier work, our data argue that all proposed mechanisms of anti-A antibody-mediated amyloid removal can be simultaneously active.
Key words: Alzheimer's disease; antibody; behavior; microglia; immunization; amyloid 
Received March 24, 2004;
revised May 12, 2004;
accepted May 13, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
D. M. Wilcock, N. Gharkholonarehe, W. E. Van Nostrand, J. Davis, M. P. Vitek, and C. A. Colton
Amyloid Reduction by Amyloid-{beta} Vaccination Also Reduces Mouse Tau Pathology and Protects from Neuron Loss in Two Mouse Models of Alzheimer's Disease
J. Neurosci.,
June 24, 2009;
29(25):
7957 - 7965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Thakker, M. R. Weatherspoon, J. Harrison, T. E. Keene, D. S. Lane, W. F. Kaemmerer, G. R. Stewart, and L. L. Shafer
Intracerebroventricular amyloid-{beta} antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice
PNAS,
March 17, 2009;
106(11):
4501 - 4506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Koenigsknecht-Talboo, M. Meyer-Luehmann, M. Parsadanian, M. Garcia-Alloza, M. B. Finn, B. T. Hyman, B. J. Bacskai, and D. M. Holtzman
Rapid Microglial Response Around Amyloid Pathology after Systemic Anti-A{beta} Antibody Administration in PDAPP Mice
J. Neurosci.,
December 24, 2008;
28(52):
14156 - 14164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Boche, E. Zotova, R. O. Weller, S. Love, J. W. Neal, R. M. Pickering, D. Wilkinson, C. Holmes, and J. A. R. Nicoll
Consequence of A{beta} immunization on the vasculature of human Alzheimer's disease brain
Brain,
December 1, 2008;
131(12):
3299 - 3310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jimenez, D. Baglietto-Vargas, C. Caballero, I. Moreno-Gonzalez, M. Torres, R. Sanchez-Varo, D. Ruano, M. Vizuete, A. Gutierrez, and J. Vitorica
Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic
J. Neurosci.,
November 5, 2008;
28(45):
11650 - 11661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bolmont, F. Haiss, D. Eicke, R. Radde, C. A. Mathis, W. E. Klunk, S. Kohsaka, M. Jucker, and M. E. Calhoun
Dynamics of the Microglial/Amyloid Interaction Indicate a Role in Plaque Maintenance
J. Neurosci.,
April 16, 2008;
28(16):
4283 - 4292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Head, V. Pop, V. Vasilevko, M. Hill, T. Saing, F. Sarsoza, M. Nistor, L.-A. Christie, S. Milton, C. Glabe, et al.
A Two-Year Study with Fibrillar {beta}-Amyloid (A{beta}) Immunization in Aged Canines: Effects on Cognitive Function and Brain A{beta}
J. Neurosci.,
April 2, 2008;
28(14):
3555 - 3566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Wilcock, M. R. Lewis, W. E. Van Nostrand, J. Davis, M. L. Previti, N. Gharkholonarehe, M. P. Vitek, and C. A. Colton
Progression of Amyloid Pathology to Alzheimer's Disease Pathology in an Amyloid Precursor Protein Transgenic Mouse Model by Removal of Nitric Oxide Synthase 2
J. Neurosci.,
February 13, 2008;
28(7):
1537 - 1545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. He, Z. Zhong, K. Lindholm, L. Berning, W. Lee, C. Lemere, M. Staufenbiel, R. Li, and Y. Shen
Deletion of tumor necrosis factor death receptor inhibits amyloid {beta} generation and prevents learning and memory deficits in Alzheimer's mice
J. Cell Biol.,
August 27, 2007;
178(5):
829 - 841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Prada, M. Garcia-Alloza, R. A. Betensky, S. X. Zhang-Nunes, S. M. Greenberg, B. J. Bacskai, and M. P. Frosch
Antibody-Mediated Clearance of Amyloid-{beta} Peptide from Cerebral Amyloid Angiopathy Revealed by Quantitative In Vivo Imaging
J. Neurosci.,
February 21, 2007;
27(8):
1973 - 1980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Benchenane, H. Castel, M. Boulouard, R. Bluthe, M. Fernandez-Monreal, B. D. Roussel, J. P. Lopez-Atalaya, S. Butt-Gueulle, V. Agin, E. Maubert, et al.
Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory
J. Cell Sci.,
February 15, 2007;
120(4):
578 - 585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Jack Jr, M. Marjanska, T. M. Wengenack, D. A. Reyes, G. L. Curran, J. Lin, G. M. Preboske, J. F. Poduslo, and M. Garwood
Magnetic Resonance Imaging of Alzheimer's Pathology in the Brains of Living Transgenic Mice: A New Tool in Alzheimer's Disease Research
Neuroscientist,
February 1, 2007;
13(1):
38 - 48.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Levites, L. A. Smithson, R. W. Price, R. S. Dakin, B. Yuan, M. R. Sierks, J. Kim, E. McGowan, D. K. Reed, T. L. Rosenberry, et al.
Insights into the mechanisms of action of anti-A{beta} antibodies in Alzheimer's disease mouse models
FASEB J,
December 1, 2006;
20(14):
2576 - 2578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Levites, K. Jansen, L. A. Smithson, R. Dakin, V. M. Holloway, P. Das, and T. E. Golde
Intracranial Adeno-Associated Virus-Mediated Delivery of Anti-Pan Amyloid beta, Amyloid beta40, and Amyloid beta42 Single-Chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein Mice.
J. Neurosci.,
November 15, 2006;
26(46):
11923 - 11928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-W. Klafki, M. Staufenbiel, J. Kornhuber, and J. Wiltfang
Therapeutic approaches to Alzheimer's disease
Brain,
November 1, 2006;
129(11):
2840 - 2855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Zamora, A. Handisurya, S. Shafti-Keramat, D. Borchelt, G. Rudow, K. Conant, C. Cox, J. C. Troncoso, and R. Kirnbauer
Papillomavirus-Like Particles Are an Effective Platform for Amyloid-beta Immunization in Rabbits and Transgenic Mice
J. Immunol.,
August 15, 2006;
177(4):
2662 - 2670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Wilcock, J. Alamed, P. E. Gottschall, J. Grimm, A. Rosenthal, J. Pons, V. Ronan, K. Symmonds, M. N. Gordon, and D. Morgan
Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.
J. Neurosci.,
May 17, 2006;
26(20):
5340 - 5346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maier, T. J. Seabrook, N. D. Lazo, L. Jiang, P. Das, C. Janus, and C. A. Lemere
Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
J. Neurosci.,
May 3, 2006;
26(18):
4717 - 4728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Lee, L. Z. Leng, B. Zhang, L. Kwong, J. Q. Trojanowski, T. Abel, and V. M.-Y. Lee
Targeting Amyloid-beta Peptide (Abeta) Oligomers by Passive Immunization with a Conformation-selective Monoclonal Antibody Improves Learning and Memory in Abeta Precursor Protein (APP) Transgenic Mice
J. Biol. Chem.,
February 17, 2006;
281(7):
4292 - 4299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cordle, J. Koenigsknecht-Talboo, B. Wilkinson, A. Limpert, and G. Landreth
Mechanisms of Statin-mediated Inhibition of Small G-protein Function
J. Biol. Chem.,
October 7, 2005;
280(40):
34202 - 34209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Koenigsknecht-Talboo and G. E. Landreth
Microglial Phagocytosis Induced by Fibrillar {beta}-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines
J. Neurosci.,
September 7, 2005;
25(36):
8240 - 8249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rebe and B. Solomon
Deglycosylation of anti-{beta} amyloid antibodies inhibits microglia activation in BV-2 cellular model
American Journal of Alzheimer's Disease and Other Dementias,
September 1, 2005;
20(5):
303 - 313.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Hartman, Y. Izumi, K. R. Bales, S. M. Paul, D. F. Wozniak, and D. M. Holtzman
Treatment with an Amyloid-{beta} Antibody Ameliorates Plaque Load, Learning Deficits, and Hippocampal Long-Term Potentiation in a Mouse Model of Alzheimer's Disease
J. Neurosci.,
June 29, 2005;
25(26):
6213 - 6220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Arbel, I. Yacoby, and B. Solomon
Inhibition of amyloid precursor protein processing by {beta}-secretase through site-directed antibodies
PNAS,
May 24, 2005;
102(21):
7718 - 7723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Koenigsknecht and G. Landreth
Microglial Phagocytosis of Fibrillar {beta}-Amyloid through a {beta}1 Integrin-Dependent Mechanism
J. Neurosci.,
November 3, 2004;
24(44):
9838 - 9846.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|